SCHEMBL14976591

SCHEMBL14976591

CC(C)(C)OC(=O)NC1(c2ccc(-n3c(-c4ccccc4)cc4nccnc43)cc2)CCC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 5/20 0.46
▸ AKT2 P31751 1/20 0.46
▸ CNR1 P21554 2/20 0.43
▸ CNR2 P34972 2/20 0.43
▸ CCNB2 O95067 1/20 0.38
▸ CDK1 P06493 1/20 0.38
▸ CCNB1 P14635 1/20 0.38
▸ CDK5 Q00535 1/20 0.38
▸ CDK5R1 Q15078 1/20 0.38
▸ CCNB3 Q8WWL7 1/20 0.38
▸ SCN9A Q15858 4/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ KIT P10721 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ PDE2A O00408 2/20 0.35
▸ TACR3 P29371 2/20 0.34
▸ LPAR1 Q92633 1/20 0.34
▸ SCN10A Q9Y5Y9 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14977636 0.89 AKT1 (0.48) AKT1AKT2CNR1CNR2SCN9A
SCHEMBL14976448 0.83 AKT1 (0.43) AKT1AKT2CNR1CNR2KIT
SCHEMBL14977403 0.83 AKT1 (0.55) AKT1AKT2CNR1CNR2SCN9A
SCHEMBL14977162 0.82 AKT1 (0.45) AKT1AKT2CNR1CNR2KIT
SCHEMBL14976175 0.82 CNR1 (0.44) AKT1AKT2CNR1CNR2SCN9A
SCHEMBL14975461 0.82 AKT1 (0.43) AKT1AKT2CNR1CNR2KIT
SCHEMBL14977316 0.81 AKT1 (0.47) AKT1AKT2CNR1CNR2SCN9A
SCHEMBL14976132 0.81 AKT1 (0.44) AKT1AKT2CNR1CNR2KIT
SCHEMBL14977671 0.81 AKT1 (0.45) AKT1AKT2CNR1CNR2KIT
SCHEMBL14976251 0.79 AKT1 (0.43) AKT1AKT2CNR1CNR2KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013078254-A1 BICYCLIC HETEROARYL DERIVATIVES AS KINASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2013-05-30 — — WO disclosed
Send feedback